ZENAPAX 25MG INJ

Overview

ZENAPAX 25MG INJ is a Schedule H drug.

ZENAPAX 25MG INJ is composed of: DACLIZUMAB (25.0 MG)

Daclizumab is a monoclonal antibody that affects the actions of the body’s immune system. Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help to protect healthy cells from damage. Daclizumab is used to treat relapsing forms of multiple scleroasis. Daclizumab is usually given when other medicines have not been effective.

Usage

DACLIZUMAB is generally used to treat: Multiple Sclerosis

Frequently Asked Questions

Q: Is it safe for children?
A: Ask your doctor

Q: Can it be taken during pregnancy?
A: Considered as Generally Safe – not enough studies to prove risk

Precautions


Do not receive a "live" vaccine while using daclizumab and for at least 4 months after your last dose. Caution should be exercised in patients with any allergy, during pregnancy and breastfeeding.  It may cause dizziness or blurred vision, do not drive a car or operate machinery while taking this medication. It may affect blood sugar level; monitor sugar level regularly while taking this medication.

Common Side-Effects

DACLIZUMAB : Dark Colored (brown) Urine, Fatigue (tiredness), Weakness (generalized), Loss Of Appetite, Abdomen Pain, Vomit, Eyes Yellow Eyes

Serious Side-Effects

DACLIZUMAB : Cloudy Urine With Strong Odor, Body Pain, Cough, Hoarse Voice, Head Headache, Nasal Congestion, Runny Nose, Throat Soreness

Rare Side-Effects

DACLIZUMAB : Frightening Thoughts, Bloody Or Red Colored Stools

Disease Interactions

DACLIZUMAB can interfere with: Depression, Bacterial Infection, Fungal Infection, Acute Liver Failure, Tuberculosis, Psoriasis, Eczema

Technical Classification

DACLIZUMAB is categorized as: SELECTIVE IMMUNOSUPPRESSANTS / IMMUNOSUPPRESSIVE AGENTS / IMMUNOLOGIC AGENTS

Available Alternatives

What are the commonly available Substitutes?

DACLIZUMABDACLIZUMAB
ZENAPAX 25MG INJINR 23920 for 5 ML INJECTIONDACLIZUMAB 25.0 MG